Getting to grips with the complexity of disease proteins

October 21, 2008

Drug molecules seldom act simply on one protein but on protein complexes and networks. A deeper understanding of these 'cooperative assemblies' should lead to better targeting of drugs.

New research into how proteins in human cells interact and 'talk' to each other is leading to a better understanding of how drug molecules work and should result in more effective therapies, according to a leading European scientist.

"Most of the time the mechanism of action of drugs is ill understood and we often do not even know the primary target of the drugs we swallow daily," Professor Giulio Superti-Furga of the Centre for Molecular Medicine of the Austrian Academy of Sciences said. "We do not know how these drugs work at the molecular level, and side effects can have serious consequences."

Superti-Furga was speaking at the European Science Foundation's 3rd Functional Genomics Conference in Innsbruck, Austria, held on 1-4 October. Functional genomics describes the way in which genes and their products, proteins, interact together in complex networks in living cells. If these interactions are abnormal, diseases can result. The Innsbruck meeting brought together more than 450 scientists from across Europe to discuss recent advances in the role of functional genomics in disease.

Our lack of understanding of the way that drugs work is illustrated by the fact that around four in ten drugs currently on the market were developed for one use but were subsequently found to be better for a different condition.

Researchers such as Superti-Furga are taking a taking a 'proteomics' approach to understanding precisely how certain proteins that are key drug targets organise themselves in the cell, and how they make complex interactions with often dozens of other proteins. "Proteomics is a way of joining the dots together to give us the bigger picture," he said.

Superti-Furga's team has been investigating a particular enzyme, a tyrosine kinase called Bcr-Abl, which is involved in leukaemia. A drug is available that acts on the enzyme, but it eventually loses its efficiency as patients become resistant to it. "We need to understand the relationship between the drug and the target," said Superti-Furga. "Can we understand the 3-d protein as a molecular machine much better?"

Superti-Furga's lab in Vienna has used a range of proteomics techniques to isolate the enzyme and dissect its constituent parts. They discovered that the protein exists as a complex of some 46 separate components and operates as a giant molecular machine, with each part in close communication with the others.

"It is clear that tyrosine kinase inhibitors do not simply inhibit the enzyme, but rather remodel the machine," Superti-Furga aid. "So drugs do not simply ablate things, they interfere with the equilibria of networks. If we can understand how these proteins interact, in the future people might say we should target this pathway or that network'; by targeting multiple nodes we will be able to maximise the good side effects against the bad side effects."

The team has also been developing methods to understand how the human body can recognise invading foreign genetic material - comprising nucleic acids - from bacteria or viruses for example, and distinguish it from its own, innate genetic material.

It is thought that proteins in the human cell can tell if a sequence of nucleic acids is from an invading organism. To try to identify these proteins the research team has developed a technique to test which proteins in a cell bind specifically to foreign nucleic acids. They have also observed which genes in the cell are switched on or 'up regulated' when foreign genetic material is present - and whether the proteins that are encoded by these genes are the same as those that bind to the material. A number of candidate proteins have emerged from this process and are undergoing further study.

The work will provide important insights into how the body defends itself against invading organisms.

European Science Foundation

---

---

	The Paraoxonases: Their Role in Disease Development and Xenobiotic Metabolism (Proteins and Cell Regulation) by Bharti Mackness (Editor), Mike Mackness (Editor), Michael Aviram (Editor), György Paragh (Editor) In September 2006 the 2nd International Conference on Paraoxonases took place in Hajdúszoboszló, Hungary, bringing together the world's foremost experts in the field. The current book is a distillation of the plenary lectures which took place at the meeting, resulting in a comprehensive up-to-date, state-of-the-art review of current paraoxonase research. The book details a unique and novel enzyme whose physiological/pathological function(s) are just starting to be revealed.
	Protein Chaperones and Protection from Neurodegenerative Diseases (Wiley Series in Protein and Peptide Science) by Stephan N. Witt (Editor), Vladimir Uversky (Editor) How protein chaperones protect cells from neurodegenerative diseasesIncluding contributions from leading experts, Protein Chaperones and Protection from Neurodegenerative Diseases provides an in-depth exploration of how protein chaperones are involved in shielding cells from toxic aggregated or misfolded protein states that cause ALS, Parkinson's, and related diseases.Examining how different protein chaperones ameliorate the toxicity of proteins that are known to cause neurodegenerative damage, the book addresses both research and clinical perspectives on chaperone and anti-chaperone properties. The intersection of molecular chaperones and neurodegeneration is an intensely studied area, partly because of the potential for manipulating the expression of molecular chaperones to thwart the...
	Coping with Kidney Disease: A 12-Step Treatment Program to Help You Avoid Dialysis by Mackenzie Walser (Author), Betsy Thorpe (Author) A revolutionary program that can indefinitely postpone the need for dialysis If you've been diagnosed with kidney failure, this book could save your life. If you suffer from diabetes, hypertension, obesity, or any of a host of conditions that put you at risk for kidney disease, you owe it to yourself to read what is in this book. If you are among the 60,000 North Americans who go on dialysis each year, the information in this book could substantially improve your quality of life. In Coping with Kidney Disease, a leading expert tells you, in plain English, what you need to know to: * Understand kidney failure * Recognize early warning signs of kidney failure * Get a proper diagnosis * Talk with your doctors about it * Confidently evaluate treatment options *...
	C-reactive protein levels may predict cardiovascular risk. (Patients on Statins).: An article from: Family Practice News by Patrice G.W. Norton (Author) This digital document is an article from Family Practice News, published by International Medical News Group on March 1, 2003. The length of the article is 1422 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser. Citation Details Title: C-reactive protein levels may predict cardiovascular risk. (Patients on Statins). Author: Patrice G.W. Norton Publication: Family Practice News (Magazine/Journal) Date: March 1, 2003 Publisher: International Medical News Group Volume: 33 Issue: 5 Page: 12(1) Distributed by Thomson...
	C-Reactive Protein and High-Sensitivity C-Reactive Protein: An Update for Clinicians (DOI: 10.3810/pgm.2011.01.2252) (Postgraduate Medicine) by JTE Multimedia The measurement of C-reactive protein (CRP) using both standard and high-sensitivity CRP (hs-CRP) assays is becoming common in clinical practice. This article addresses the causes of CRP elevation and the use of different CRP assays in internal medicine, including cardiology, gastroenterology, rheumatology, infectious diseases, and oncology. We focus on the recent medical literature on the use of hs-CRP in cardiovascular disease risk stratification and management, including updated screening guidelines on the use of hs-CRP, such as those issued in 2009 by the Canadian Cardiovascular Society. We also discuss the Reynolds Risk Score, which incorporates hs-CRP and family history with more standard cardiovascular risk factors (eg, tobacco use, hypertension, and dyslipidemia) and frequently...
	Myb Transcription Factors: Their Role in Growth, Differentiation and Disease (Proteins and Cell Regulation) by Jon Frampton (Editor) This volume represents the first collection of articles contributed by research leaders working on the Myb family of transcriptional regulatory proteins. In more than twenty chapters the authors discuss the range of biological processes and diverse cell types in which Myb proteins operate. Although concentrating on the three vertebrate Myb family members, homologues from lower species are also discussed because of the light they are able to shed on the evolution and function of these proteins. Individual chapters describe the involvement of Myb proteins, in particular c-Myb, in normal and diseased development and function of many tissues including haemopoietic cells, blood vessels, the gastrointestinal tract and the brain. Several chapters explore the mechanistic details of the action of...
	Protein Misfolding Diseases: Current and Emerging Principles and Therapies (Wiley Series in Protein and Peptide Science) by Marina Ramirez-Alvarado (Editor), Jeffery W. Kelly (Editor), Christopher M. Dobson (Editor) An increasingly aging population will add to the number of individuals suffering from amyloid. Protein Misfolding Diseases provides a systematic overview of the current and emerging therapies for these types of protein misfolding diseases, including Alzheimer's, Parkinson's, and Mad Cow. The book emphasizes therapeutics in an amyloid disease context to help students, faculty, scientific researchers, and doctors working with protein misfolding diseases bridge the gap between basic science and pharmaceutical applications to protein misfolding disease.
	Post-Translational Modifications in Health and Disease (Protein Reviews) by Cecilio J. Vidal (Editor) Post-translational modifications serve many different purposes in several cellular processes such as gene expression, protein folding and transport to appropriate cell compartment, protein-lipid and protein-protein interactions, enzyme regulation, signal transduction, cell proliferation and differentiation, protein stability, recycling and degradation. Although several-hundred different modifications are known, the significance of many of them remains unknown. The enormous versatility of the modifications which frequently alter the physico-chemical properties of the respective proteins represents an extraordinary challenge in understanding their physiological role. Since essential cellular functions are regulated by protein modifications, an improvement of current understanding of their...
	Emerging Drugs and Targets for Alzheimer's Disease: Volume 1: Beta-Amyloid, Tau Protein and Glucose Metabolism (RSC Drug Discovery) by Ana Martinez (Editor), David E Thurston (Editor) Alzheimer's disease is the most prevalent neurodegenerative disorder in the elderly. A recent study from the Bloomberg School of Public Health recently estimated that over 26 million people were living with the disease in 2006 and that the global prevalence of the disease will grow to 106 million by 2050. By that time, 43 per cent of those living with the disease will need high-level care, equivalent to that of a nursing home. However, even if modest advances in preventing or delaying the disease's progression were made, it could have a huge impact on global public health. According to this study, interventions that could delay the onset of the disease by as little as one year would reduce the prevalence of the disease by 12 million fewer cases in 2050. These figures reinforce how...
	Protein Microarray for Disease Analysis: Methods and Protocols (Methods in Molecular Biology) by Catherine J. Wu (Editor) Protein microarrays have been used for a wide variety of important tasks, such as identifying protein-protein interactions, discovering disease biomarkers, identifying DNA-binding specificity by protein variants, and for characterization of the humoral immune response.  In Protein Microarray for Disease Analysis: Methods and Protocols, expert researchers provide concise descriptions of the methodologies currently used to fabricate microarrays for the comprehensive analysis of proteins or responses to proteins that can be used to dissect human disease.  These methodologies are the toolbox for revolutionizing drug development and cell-level biochemical understanding of human disease processes.  Beginning with a section on protein-detecting analytical microarrays, the volume continues...